Integrated genomic approaches to identify the molecular pathogenesis of schizophrenia
博士 === 慈濟大學 === 醫學研究所 === 98 === Schizophrenia is a common psychiatric disorder with a prevalence of approximately 1 % of the general population worldwide (0.3~1 % in Taiwan) and is characterized by psychotic symptoms such as hallucinations, delusions and bizarre behaviors. Despite a high heritabil...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_US |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/75133634106353627105 |
id |
ndltd-TW-098TCU05534006 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-098TCU055340062016-04-22T04:23:29Z http://ndltd.ncl.edu.tw/handle/75133634106353627105 Integrated genomic approaches to identify the molecular pathogenesis of schizophrenia 以整合性基因組方法研究精神分裂症的分子致病機轉 Min-Chih Cheng 鄭敏志 博士 慈濟大學 醫學研究所 98 Schizophrenia is a common psychiatric disorder with a prevalence of approximately 1 % of the general population worldwide (0.3~1 % in Taiwan) and is characterized by psychotic symptoms such as hallucinations, delusions and bizarre behaviors. Despite a high heritability of about 80 %, the major genetic components underlying the disease’s susceptibility and pathology have remained elusive. Aripiprzole is an antipsychotic drug, while methamphetamine (MAP) is a psychotomimetic drug that can induce psychotic symptoms in human. Using cDNA microarry, we found that the Egr1, Egr2 and Egr4 genes were up-regulated in the rat frontal cortex under chronic treatment of aripiprazole. In the pharmacological model of psychosis, we detected increased expression of the Egr1 and Egr3 proteins in the mouse hippocampus after 4 weeks’s administration of methamphetamine (MAP, 1 mg/kg/day), and increased expression of Egr1 and Egr4 proteins in the mouse hippocampus after 4 weeks’s treatment with MK-801 (0.5 mg/kg/day), respectively, suggesting EGR protein family might be involved in the moelcular mechanism of antipsychotic and psychotomimetic drugs. In further genetic association studies between the EGR family genes and schizophrenia in Han Chinese samples from Taiwan (564 patients and 564 control subjects), we found a significant over-representation of the C/C homozygotes of the rs9990 of the EGR2 gene in female patients compared to female controls. Western blot analysis also showed a significantly higher EGR2 protein level in the lymphoblastoid cells of female patients than that in the female control subjects. In addition, we also detected an association of the EGR4 gene with male schizophrenia in this study. There were significant over-representations of the T/T homozygotes of the rs6747506, the A/A homozygotes of the rs6718289, the T/T homozygotes of the rs2229294, and the A/A homozygotes of the rs3813226 in male schizophrenia patients as compared to male control subjects. Reporter gene assay revealed that the haplotype T-A (rs6747506- rs6718289) had significantly lower promoter activities than A-G, indicating that lower EGR4 activity is associated with schizophrenia. In summary, our data suggest that EGR protein family might be involved in the pathogenesis of schizophrenia. Chia-Hsiang Chen 陳嘉祥 2010/07/ 學位論文 ; thesis 126 en_US |
collection |
NDLTD |
language |
en_US |
format |
Others
|
sources |
NDLTD |
description |
博士 === 慈濟大學 === 醫學研究所 === 98 === Schizophrenia is a common psychiatric disorder with a prevalence of approximately 1 % of the general population worldwide (0.3~1 % in Taiwan) and is characterized by psychotic symptoms such as hallucinations, delusions and bizarre behaviors. Despite a high heritability of about 80 %, the major genetic components underlying the disease’s susceptibility and pathology have remained elusive. Aripiprzole is an antipsychotic drug, while methamphetamine (MAP) is a psychotomimetic drug that can induce psychotic symptoms in human. Using cDNA microarry, we found that the Egr1, Egr2 and Egr4 genes were up-regulated in the rat frontal cortex under chronic treatment of aripiprazole. In the pharmacological model of psychosis, we detected increased expression of the Egr1 and Egr3 proteins in the mouse hippocampus after 4 weeks’s administration of methamphetamine (MAP, 1 mg/kg/day), and increased expression of Egr1 and Egr4 proteins in the mouse hippocampus after 4 weeks’s treatment with MK-801 (0.5 mg/kg/day), respectively, suggesting EGR protein family might be involved in the moelcular mechanism of antipsychotic and psychotomimetic drugs. In further genetic association studies between the EGR family genes and schizophrenia in Han Chinese samples from Taiwan (564 patients and 564 control subjects), we found a significant over-representation of the C/C homozygotes of the rs9990 of the EGR2 gene in female patients compared to female controls. Western blot analysis also showed a significantly higher EGR2 protein level in the lymphoblastoid cells of female patients than that in the female control subjects. In addition, we also detected an association of the EGR4 gene with male schizophrenia in this study. There were significant over-representations of the T/T homozygotes of the rs6747506, the A/A homozygotes of the rs6718289, the T/T homozygotes of the rs2229294, and the A/A homozygotes of the rs3813226 in male schizophrenia patients as compared to male control subjects. Reporter gene assay revealed that the haplotype T-A (rs6747506- rs6718289) had significantly lower promoter activities than A-G, indicating that lower EGR4 activity is associated with schizophrenia. In summary, our data suggest that EGR protein family might be involved in the pathogenesis of schizophrenia.
|
author2 |
Chia-Hsiang Chen |
author_facet |
Chia-Hsiang Chen Min-Chih Cheng 鄭敏志 |
author |
Min-Chih Cheng 鄭敏志 |
spellingShingle |
Min-Chih Cheng 鄭敏志 Integrated genomic approaches to identify the molecular pathogenesis of schizophrenia |
author_sort |
Min-Chih Cheng |
title |
Integrated genomic approaches to identify the molecular pathogenesis of schizophrenia |
title_short |
Integrated genomic approaches to identify the molecular pathogenesis of schizophrenia |
title_full |
Integrated genomic approaches to identify the molecular pathogenesis of schizophrenia |
title_fullStr |
Integrated genomic approaches to identify the molecular pathogenesis of schizophrenia |
title_full_unstemmed |
Integrated genomic approaches to identify the molecular pathogenesis of schizophrenia |
title_sort |
integrated genomic approaches to identify the molecular pathogenesis of schizophrenia |
publishDate |
2010 |
url |
http://ndltd.ncl.edu.tw/handle/75133634106353627105 |
work_keys_str_mv |
AT minchihcheng integratedgenomicapproachestoidentifythemolecularpathogenesisofschizophrenia AT zhèngmǐnzhì integratedgenomicapproachestoidentifythemolecularpathogenesisofschizophrenia AT minchihcheng yǐzhěnghéxìngjīyīnzǔfāngfǎyánjiūjīngshénfēnlièzhèngdefēnzizhìbìngjīzhuǎn AT zhèngmǐnzhì yǐzhěnghéxìngjīyīnzǔfāngfǎyánjiūjīngshénfēnlièzhèngdefēnzizhìbìngjīzhuǎn |
_version_ |
1718230683350990848 |